Document

Filter documents Clear search

pdf icon

FSRH CEU Statement: Provision of LARC methods to young women in the UK (July 2015)

File size: 219kb | Date: 1 July 2015 | Clinical Statements - PDF

The recent article in the Telegraph newspaper has highlighted the complex issues surrounding sexual activity in young women in the UK. Whilst it is true that the legal age of consent to sexual activity in the UK is 16 years, surveys suggest that almost one in three young people will have had sexual intercourse by this age.

pdf icon

FSRH CEU Statement: Depot Medroxyprogesterone Acetate (DMPA, Depo- Provera) and Risk of HIV Acquisition (January 2015)

File size: 297kb | Date: 1 January 2015 | Clinical Statements - PDF

Progestogen-only injectable contraception is widely used across the world and is particularly popular in resource poor countries with a high incidence of HIV infection e.g. in sub-Saharan Africa. It is clearly important therefore to establish whether there is any relationship between the use of injectable contraception and increased risk of HIV acquisition.

pdf icon

FSRH CEU Statement: Oral Contraceptives and Multiple Sclerosis (March 2014)

File size: 59kb | Date: 1 March 2014 | Clinical Statements - PDF

Various news stories have reported the findings detailed in the AAN press release which stated that compared to women who did not use hormonal contraceptives, women who did, were 35 percent more likely to develop Multiple Sclerosis and that the findings suggested that hormonal contraception may be contributing to the rise in the rate of MS among women.

pdf icon

FSRH CEU Statement: St Johns Wort and Hormonal Contraception (March 2014)

File size: 102kb | Date: 1 March 2014 | Clinical Statements - PDF

St Johns wort is a herbal product that is used for depressive symptoms and is known to have enzyme-inducing effects on cytochrome p450 enzymes. The MHRA statement highlights that in the last quarter of 2013, two ‘Yellow Card’ reports were received relating to unplanned pregnancies, in women with progestogen-only implants, suspected to be the result of an interaction with St John’s wort.

pdf icon

FSRH CEU Statement: Response to new reports of link between COC and Glaucoma (November 2013)

File size: 55kb | Date: 1 November 2013 | Clinical Statements - PDF

Following a presentation at the annual meeting of the American Academy of Ophthalmology a number of media reports have reported a possible link between use of combined oral contraception (COC) and glaucoma. There is limited data investigating combined hormonal contraceptives on glaucoma. One cohort study suggested that 5 or more years of COC use was associated with a 25% increase in the risk of glaucoma. Two UK cohort studies did not find consistent evidence of an increased risk.